Is Thyroid Inadequacy During Gestation a Risk Factor for Adverse Pregnancy and Developmental Outcomes?
Authors:
- 1 January 2005
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 15 (1) , 60-71
Abstract
A workshop entitled, "The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening," was held in Atlanta, Georgia, January 12–13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: "Adverse Pregnancy Outcomes"; "Thyroid Physiology in the Fetus"; "New England Data: Cretinism Revisited—Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism"; "Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring"; and "Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT." These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7–8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12–14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.Keywords
This publication has 39 references indexed in Scilit:
- Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation?BJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Pregnancy outcomes in women with subclinical hypothyroidismAmerican Journal of Obstetrics and Gynecology, 2003
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- Maternal Hypothyroidism and Child DevelopmentHormone Research in Paediatrics, 1999
- The Hypothyroxinemia of PrematurityThe Journal of Clinical Endocrinology & Metabolism, 1998
- Neonatal Hypothyroxinemia: Effects of Iodine Intake and Premature BirthThe Journal of Clinical Endocrinology & Metabolism, 1997
- Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacementClinical Endocrinology, 1995
- Maternal hypothyroidism during early pregnancy and intellectual development of the progenyArchives of internal medicine (1960), 1994
- Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodiesJAMA, 1990
- Maternal-Fetal Transfer of Thyroxine in Congenital Hypothyroidism Due to a Total Organification Defect or Thyroid AgenesisNew England Journal of Medicine, 1989